Categories: The Charlton Centre

World Hepatitis Day – Friday July 28th

This Friday July 28th is World Hepatitis Day.  The World Health Organization’s Global Strategy on viral hepatitis is to eliminate hepatitis B and C by 2030.  Governments from 194 countries, adopted this goal at the 69th World Health Assembly meeting in Geneva, Switzerland.

There are several ways we can all work towards achieving this goal:

  • receive a Hepatitis A and B vaccine
  • ask for a Hepatitis B and C blood screening blood test to see if you unknowingly are carrying and potentially spreading this virus
  • never share needles with another person and  seek out treatment if you have Hepatitis.

Viral hepatitis causes inflammation of the liver which can lead to liver failure and an increased risk of liver cancer.  Approximately 250,000 Canadians are living with Hepatitis C and many are unaware that they have it as symptoms can be silent for many years.

Charlton Health is proud to provide specialized treatments for patients living with Hepatitis C.  These treatments offer a cure for most patients.  We are happy to answer questions about these treatments  and to advise on available vaccines.  For more information on World Hepatitis Day, visit their website.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago